Not independent
Tenure on this board
22.7 yrs
10 nominees · 1 ballot item.
Approve, for compliance with Nasdaq Listing Rule 5635(c), the grant of a 1,000,000-share option to Executive Chairman Ali Mazanderani under a Share Option Agreement; Board recommends FOR.
Shareholders are asked to approve a board-granted option award of 1,000,000 options to Executive Chairman Ali Mazanderani at an exercise price of $5.00 per share, subject to vesting based on continuous employment through April 1, 2028 and exercisable after April 1, 2029; approval is required to comply with Nasdaq Listing Rule 5635(c).
This management proposal asks shareholders to ratify a board-approved share option award to Executive Chairman Ali Mazanderani—1,000,000 options at a $5.00 exercise price—so the company complies with Nasdaq Listing Rule 5635(c). Management seeks shareholder approval because the Option Agreement conditions issuance on shareholder authorization and the option would otherwise be forfeited; Nasdaq rules require shareholder approval for equity awards to officers. The award vests only if Mr. Mazanderani remains continuously employed through April 1, 2028, is exercisable after April 1, 2029, and expires April 1, 2030, with no automatic acceleration on termination or change in control absent committee action. The option is structured to align his incentives with shareholders by delivering value only if the share price appreciates above the exercise price and by providing a near-term incentive relative to his existing out-of-the-money prior awards. Company disclosure flags potential dilution and accounting expense (ASC 718) and estimates a grant-date fair value and expected compensation charges over fiscal years if approved and vested. The Board’s stated rationale emphasizes retention of a key executive and alignment of long-term shareholder value, while the materials disclose that the award is not granted under the 2022 stock incentive plan and that the committee has broad discretion over administration, exercise methods, and adjustments for corporate events. Key governance considerations for investors include the relatively large size of the grant (1,000,000 options, potential incremental ownership impact), lack of special acceleration protections for termination or change in control, the exercise price relative to market at grant, and the tax/deduction limitations under Section 162(m). Overall, the proposal is a routine Nasdaq-rule compliance vote that also raises standard executive-compensation governance issues (dilution, vesting conditions, alignment vs. near-term incentivization) that investors should weigh against the Board’s retention and alignment arguments.
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | MORGAN STANLEY | 5.95% | 5,107,635 | $25M |
| 2 | GOLDMAN SACHS GROUP INC | 5.89% | 5,053,010 | $25M |
| 3 | Rathbones Group PLC | 4.26% | 3,657,420 | $18M |
| 4 | Hosking Partners LLP | 3.17% | 2,724,153 | $14M |
| 5 | Potomac Capital Management, Inc. | 1.77% | 1,515,000 | $8M |
| 6 | Kingsway Capital Partners Ltd | 1.07% | 919,888 | $5M |
| 7 | DEUTSCHE BANK AG\ | 0.51% | 439,307 | $2M |
| 8 | CITADEL ADVISORS LLC | 0.47% | 400,414 | $2M |
| 9 | BARCLAYS PLC | 0.29% | 250,350 | $1M |
| 10 | INTREPID FAMILY OFFICE LLC | 0.29% | 250,000 | $1M |
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.